BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36798478)

  • 1. Signaling Modulation via Minimal C-Terminal Modifications of Apelin-13.
    Théroux L; Van Den Hauwe R; Trân K; Fournier J; Desgagné M; Meneboo N; Lavallée A; Fröhlich U; Côté J; Hollanders C; Longpré JM; Murza A; Marsault E; Sarret P; Boudreault PL; Ballet S
    ACS Pharmacol Transl Sci; 2023 Feb; 6(2):290-305. PubMed ID: 36798478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size-Reduced Macrocyclic Analogues of [Pyr
    Tran K; Sainsily X; Côté J; Coquerel D; Couvineau P; Saibi S; Haroune L; Besserer-Offroy É; Flynn-Robitaille J; Resua Rojas M; Murza A; Longpré JM; Auger-Messier M; Lesur O; Bouvier M; Marsault É; Boudreault PL; Sarret P
    J Med Chem; 2022 Jan; 65(1):531-551. PubMed ID: 34982553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constraining the Side Chain of C-Terminal Amino Acids in Apelin-13 Greatly Increases Affinity, Modulates Signaling, and Improves the Pharmacokinetic Profile.
    Trân K; Van Den Hauwe R; Sainsily X; Couvineau P; Côté J; Simard L; Echevarria M; Murza A; Serre A; Théroux L; Saibi S; Haroune L; Longpré JM; Lesur O; Auger-Messier M; Spino C; Bouvier M; Sarret P; Ballet S; Marsault É
    J Med Chem; 2021 May; 64(9):5345-5364. PubMed ID: 33524256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor.
    Trân K; Murza A; Sainsily X; Delile E; Couvineau P; Côté J; Coquerel D; Peloquin M; Auger-Messier M; Bouvier M; Lesur O; Sarret P; Marsault É
    J Med Chem; 2021 Jan; 64(1):602-615. PubMed ID: 33350824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypotensive effect of activated apelin receptor is correlated with β-arrestin recruitment.
    Besserer-Offroy É; Bérubé P; Côté J; Murza A; Longpré JM; Dumaine R; Lesur O; Auger-Messier M; Leduc R; Marsault É; Sarret P
    Pharmacol Res; 2018 May; 131():7-16. PubMed ID: 29530600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles.
    Jiang Y; Yan M; Wang C; Wang Q; Chen X; Zhang R; Wan L; Ji B; Dong B; Wang H; Chen J
    Front Pharmacol; 2021; 12():630548. PubMed ID: 33746758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potent pyrazole based APELIN receptor (APJ) agonists.
    Narayanan S; Vasukuttan V; Rajagopal S; Maitra R; Runyon SP
    Bioorg Med Chem; 2020 Feb; 28(4):115237. PubMed ID: 31948845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
    Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
    Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying structural determinants of potency for analogs of apelin-13: integration of C-terminal truncation with structure-activity.
    Zhang Y; Maitra R; Harris DL; Dhungana S; Snyder R; Runyon SP
    Bioorg Med Chem; 2014 Jun; 22(11):2992-7. PubMed ID: 24755525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPCR structure and function relationship: identification of a biased apelin receptor mutant.
    Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA
    Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Terminal modifications of apelin-13 significantly change ligand binding, receptor signaling, and hypotensive action.
    Murza A; Besserer-Offroy É; Côté J; Bérubé P; Longpré JM; Dumaine R; Lesur O; Auger-Messier M; Leduc R; Sarret P; Marsault É
    J Med Chem; 2015 Mar; 58(5):2431-40. PubMed ID: 25668242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction.
    Chen J; Chen X; Li S; Jiang Y; Mao H; Zhang R; Ji B; Yan M; Cai X; Wang C
    Redox Biol; 2020 Sep; 36():101629. PubMed ID: 32863206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of novel macrocyclic biased apelin receptor agonists.
    Murza A; Sainsily X; Côté J; Bruneau-Cossette L; Besserer-Offroy É; Longpré JM; Leduc R; Dumaine R; Lesur O; Auger-Messier M; Sarret P; Marsault É
    Org Biomol Chem; 2017 Jan; 15(2):449-458. PubMed ID: 27924341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man.
    Katugampola SD; Maguire JJ; Matthewson SR; Davenport AP
    Br J Pharmacol; 2001 Mar; 132(6):1255-60. PubMed ID: 11250876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biased signaling favoring gi over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine.
    Ceraudo E; Galanth C; Carpentier E; Banegas-Font I; Schonegge AM; Alvear-Perez R; Iturrioz X; Bouvier M; Llorens-Cortes C
    J Biol Chem; 2014 Aug; 289(35):24599-610. PubMed ID: 25012663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
    Chen X; Bai B; Tian Y; Du H; Chen J
    J Biol Chem; 2014 Nov; 289(45):31173-87. PubMed ID: 25271156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist.
    Brame AL; Maguire JJ; Yang P; Dyson A; Torella R; Cheriyan J; Singer M; Glen RC; Wilkinson IB; Davenport AP
    Hypertension; 2015 Apr; 65(4):834-40. PubMed ID: 25712721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor.
    Nyimanu D; Kuc RE; Williams TL; Bednarek M; Ambery P; Jermutus L; Maguire JJ; Davenport AP
    Peptides; 2019 Nov; 121():170139. PubMed ID: 31472173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.
    Deng C; Chen H; Yang N; Feng Y; Hsueh AJ
    J Biol Chem; 2015 Jul; 290(30):18261-8. PubMed ID: 25995451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.
    Szokodi I; Tavi P; Földes G; Voutilainen-Myllylä S; Ilves M; Tokola H; Pikkarainen S; Piuhola J; Rysä J; Tóth M; Ruskoaho H
    Circ Res; 2002 Sep; 91(5):434-40. PubMed ID: 12215493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.